Companies Congenica

Clinically actionable insights  from patient genomes


Based on research by the Wellcome Trust and the NHS, Congenica is pioneering the development of an end-to-end platform to interpret next generation genetic datasets and guide treatment decisions in as a little as 5 minutes.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More